TY - JOUR
T1 - Comparison of Survival and Risk Factors of Differentiated Thyroid Cancer in the Geriatric Population
AU - Yu, Lujiao
AU - Hong, Hong
AU - Han, Jinyu
AU - Leng, Sean X.
AU - Zhang, Haiyan
AU - Yan, Xu
N1 - Funding Information:
This work was supported by National Natural Science Foundation of China (Grant Nos. 81301838, 81271292, 81700977) as well as funding from the Irma and Paul Milstein Medical Asian American Partnership (MMAAP) Foundation Program for Senior Health fellow supported by the MMAAP Foundation (http://www.mmaapf.org) to Dr. HZ.
Publisher Copyright:
© Copyright © 2020 Yu, Hong, Han, Leng, Zhang and Yan.
PY - 2020/2/3
Y1 - 2020/2/3
N2 - Purpose: The incidence rate of differentiated thyroid cancer (DTC), the most common type of thyroid cancer, has increased in the past two decades. The present study analyzed the clinical and pathological characteristics of DTC, and discussed the risk factors for survival in elderly age-risk DTC patients. Methods: Elderly patients who were diagnosed with DTC, and subsequently underwent surgery for DTC, were identified from the SEER database (1988–2008). Based on histology, these patients were divided into C-PTC, FV-PTC, and FTC. The clinical characteristics, pathological features, and treatments undertaken were compared among these patients. Cox proportional hazards analysis was performed to evaluate the risk factors to disease-specific survival (DSS). Results: In elderly DTC patients, FV-PTC shows intermediate tumor features compared to C-PTC and FTC, but presented a better outcome. Being male, African-American, tumors sized bigger than 4 cm, extrathyroidal extension, lymph node metastasis, and distant metastasis, were all strong risk factors for DSS in elderly DTC patients (all p < 0.05). No difference was found between lobectomy and total thyroidectomy with respect to DSS, and radiation therapy conferred no apparent advantage with respect to DSS (both p > 0.05). Discussion: Patients with FV-PTC needed more specific histology cataloging and risk assessment, suggesting conservative therapy. Risk stratification should be paid attention to, and treatment should be individualized for elderly patients.
AB - Purpose: The incidence rate of differentiated thyroid cancer (DTC), the most common type of thyroid cancer, has increased in the past two decades. The present study analyzed the clinical and pathological characteristics of DTC, and discussed the risk factors for survival in elderly age-risk DTC patients. Methods: Elderly patients who were diagnosed with DTC, and subsequently underwent surgery for DTC, were identified from the SEER database (1988–2008). Based on histology, these patients were divided into C-PTC, FV-PTC, and FTC. The clinical characteristics, pathological features, and treatments undertaken were compared among these patients. Cox proportional hazards analysis was performed to evaluate the risk factors to disease-specific survival (DSS). Results: In elderly DTC patients, FV-PTC shows intermediate tumor features compared to C-PTC and FTC, but presented a better outcome. Being male, African-American, tumors sized bigger than 4 cm, extrathyroidal extension, lymph node metastasis, and distant metastasis, were all strong risk factors for DSS in elderly DTC patients (all p < 0.05). No difference was found between lobectomy and total thyroidectomy with respect to DSS, and radiation therapy conferred no apparent advantage with respect to DSS (both p > 0.05). Discussion: Patients with FV-PTC needed more specific histology cataloging and risk assessment, suggesting conservative therapy. Risk stratification should be paid attention to, and treatment should be individualized for elderly patients.
KW - Disease-specific survival
KW - SEER database
KW - differentiated thyroid carcinoma
KW - elderly people
KW - risk factor
UR - http://www.scopus.com/inward/record.url?scp=85079652537&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85079652537&partnerID=8YFLogxK
U2 - 10.3389/fonc.2020.00042
DO - 10.3389/fonc.2020.00042
M3 - Article
C2 - 32117715
AN - SCOPUS:85079652537
SN - 2234-943X
VL - 10
JO - Frontiers in Oncology
JF - Frontiers in Oncology
M1 - 42
ER -